[HTML][HTML] Differential drug survival of biologic therapies for the treatment of psoriasis: a prospective observational cohort study from the British Association of …
Drug survival reflects a drug's effectiveness, safety, and tolerability. We assessed the drug
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
[PDF][PDF] Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of …
RB Warren, CH Smith, ZZN Yiu… - Journal of …, 2015 - researchgate.net
Biologic therapies have revolutionized the treatment of severe psoriasis. Biologics currently
licensed for psoriasis include the tumor necrosis factor inhibitors (TNFIs)—adalimumab …
licensed for psoriasis include the tumor necrosis factor inhibitors (TNFIs)—adalimumab …
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists …
RB Warren, CH Smith, ZZN Yiu… - The Journal of …, 2015 - research.manchester.ac.uk
Drug survival reflects a drug's effectiveness, safety, and tolerability. We assessed the drug
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists …
RB Warren, CH Smith, ZZN Yiu, DM Ashcroft… - 1523 …, 2015 - escholar.manchester.ac.uk
Drug survival reflects a drug's effectiveness, safety, and tolerability. We assessed the drug
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists …
RB Warren, CH Smith, ZZN Yiu… - Journal of …, 2015 - eprints.ncl.ac.uk
Drug survival reflects a drug's effectiveness, safety, and tolerability. We assessed the drug
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists …
RB Warren, CH Smith, ZZN Yiu… - The Journal of …, 2015 - pubmed.ncbi.nlm.nih.gov
Drug survival reflects a drug's effectiveness, safety, and tolerability. We assessed the drug
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
Differential drug survival of biologic therapies for the treatment of psoriasis: a prospective observational cohort study from the British association of dermatologists …
RB Warren, CH Smith, ZZN Yiu… - Journal of …, 2015 - eprints.gla.ac.uk
Drug survival reflects a drug's effectiveness, safety, and tolerability. We assessed the drug
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists …
RB Warren, CH Smith, ZZN Yiu… - The Journal of …, 2015 - europepmc.org
Drug survival reflects a drug's effectiveness, safety, and tolerability. We assessed the drug
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists …
RB Warren, CH Smith, ZZN Yiu… - Journal of …, 2015 - kclpure.kcl.ac.uk
Drug survival reflects a drug's effectiveness, safety, and tolerability. We assessed the drug
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
survival of biologics used to treat psoriasis in a prospective national pharmacovigilance …
[PDF][PDF] Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of …
RB Warren, CH Smith, ZZN Yiu… - Journal of …, 2015 - personalpages.manchester.ac.uk
Biologic therapies have revolutionized the treatment of severe psoriasis. Biologics currently
licensed for psoriasis include the tumor necrosis factor inhibitors (TNFIs)—adalimumab …
licensed for psoriasis include the tumor necrosis factor inhibitors (TNFIs)—adalimumab …